8-K
Current Report
Apimeds Pharmaceuticals US, Inc. Filed Acc 0001213900-25-045643
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading ea024276701-8k_apimed.htm…